Pivotal RCT to Test Safety and Efficacy of Digital Therapeutics 'ANZEILAX' for Managing Generalized Anxiety Disorder
Clinical trial NCT06010654 · COMPLETED
Trial details
- NCT number
- NCT06010654
- Sponsor
- HAII corp.ltd
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-14
- Primary completion
- 2024-07-24
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.